Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-24-016878
Filing Date
2024-09-30
Accepted
2024-09-30 09:00:13
Documents
2
Group Members
KEVIN TANGTANG CAPITAL PARTNERS III, INCTANG CAPITAL PARTNERS IV, INCTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 o927246sc13g.htm SC 13G 118059
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 12038
  Complete submission text file 0001214659-24-016878.txt   131920
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001232621 (see all company filings)

EIN.: 461592449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Subject) CIK: 0001808865 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91596 | Film No.: 241336890
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)